Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne

ClinicalTrials.gov ID: NCT00776919

Public ClinicalTrials.gov record NCT00776919. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 22, 2026, 6:08 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3 Multicenter, Randomized, Double-Blind, Active And Vehicle-Controlled Study Of The Safety And Efficacy Of A Clindamycin / Benzoyl Peroxide Gel Versus Clindamycin Gel Versus Benzoyl Peroxide Gel Versus Vehicle Gel In Subjects With Acne Vulgaris

Study identification

NCT ID
NCT00776919
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Stiefel, a GSK Company
Industry
Enrollment
1,315 participants

Conditions and interventions

Conditions

Interventions

  • clindamycin / benzoyl peroxide gel Drug
  • clindamycin gel Drug
  • BPO gel Drug
  • vehicle gel Drug

Drug

Eligibility (public fields only)

Age range
12 Years to 45 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 30, 2008
Primary completion
Aug 31, 2009
Completion
Aug 31, 2009
Last update posted
Nov 22, 2016

2008 – 2009

United States locations

U.S. sites
16
U.S. states
11
U.S. cities
16
Facility City State ZIP Site status
Rady Children's Hospital San Diego, Div. of Pediatric & Adolescents Dermatology San Diego California 92123
The Laser Institute for Dermatology Santa Monica California 90404
Cherry Creek Research, Inc. Denver Colorado 80209
Skin Care Research, Inc. Boca Raton Florida 33486
FXM Research Miami Florida 33175
University of Miami Cosmetic Medicine and Research Institute Miami Beach Florida 33140
Atlanta Dermatology & Vein Research Center, LLC Alpharetta Georgia 30022
SKINQRI Lincolnshire Illinois 60069
Dawes Fretzin Clinical Research Group Indianapolis Indiana 46260
DermResearch, PLLC Louisville Kentucky 40217
Somerset Skin Centre Troy Michigan 48084
Dermatology Associates of Rochester, PC Rochester New York 14623
DermResearch Center of New York Stony Brook New York 11790
The Skin Wellness Center, PC Knoxville Tennessee 37922
Arlington Center for Dermatology Arlington Texas 76011
Progressive Clinical Research San Antonio Texas 78229

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 8 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00776919, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 22, 2016 · Synced Jul 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00776919 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →